Bruker (BRKR) Change in Accured Expenses (2011 - 2026)

Bruker (BRKR) has reported Change in Accured Expenses for 16 consecutive years, with -$91.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses fell 46.15% year-over-year to -$91.2 million; the trailing twelve-month figure through Jun 2026 stood at -$70.7 million (down 169.85% YoY), and the FY2025 full-year result was -$26.7 million, down 273.38% from the prior year.
• Change in Accured Expenses eased to -$91.2 million in Q2 2026 per BRKR's latest filing, from $11.2 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $66.2 million in Q4 2025 and bottomed at -$91.2 million in Q2 2026.
• Historically, Change in Accured Expenses has averaged -$3.1 million across 5 years, with a median of $10.0 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 13200.0% in 2023, then slumped 770.97% in 2025.
• Over 5 years, Change in Accured Expenses stood at $12.9 million in 2022, then slipped by 16.28% to $10.8 million in 2023, then sank by 202.78% to -$11.1 million in 2024, then jumped by 696.4% to $66.2 million in 2025, then sank by 237.76% to -$91.2 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$91.2 million, $11.2 million, and $66.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.